Metraipolis › archive › dc_3ca98383fa84

Prospective analysis of bleomycin electrosclerotherapy for clinical outcome and volume reduction in therapy refractory slow-flow malformations — Europe PMC PMID:41474461

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41474461
DOI
10.1186/s42155-[numero omesso]-z
License (as archived)
solo-consultazione
Archived
2026-11-07T07:29:45.129Z
SHA-256 of the archived text
ce6b5aa5956c41ef2ac3f9c249682cede747c227e69fead636898b068cc847a5
Stable URL of this page
https://metraipolis.com/documento/dc_3ca98383fa84

How to cite

Prospective analysis of bleomycin electrosclerotherapy for clinical outcome and volume reduction in therapy refractory slow-flow malformations — Europe PMC PMID:41474461 — Europe PMC (en), https://europepmc.org/article/MED/41474461 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3ca98383fa84 (Metraipolis archive dc_3ca98383fa84, sha256 ce6b5aa5956c41ef2ac3f9c249682cede747c227e69fead636898b068cc847a5)
BibTeX
@misc{dc3ca98383fa84,
  title = {Prospective analysis of bleomycin electrosclerotherapy for clinical outcome and volume reduction in therapy refractory slow-flow malformations — Europe PMC PMID:41474461},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41474461},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3ca98383fa84; sha256 ce6b5aa5956c41ef2ac3f9c249682cede747c227e69fead636898b068cc847a5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41474461. Agents can read the archived copy with the MCP tool read_document.